← Back to Search

Mindfulness Based Cognitive Therapy for Grief

N/A
Waitlist Available
Led By Jonathan D Singer, Ph.D
Research Sponsored by Texas Tech University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months
Awards & highlights

Study Summary

This trial will test if interventions can reduce the negative effects of caring for someone with dementia.

Eligible Conditions
  • Mental Health Issue
  • Grief
  • Caregiver Burden

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prolonged Grief Scale-12 (measuring pre-death grief)
Secondary outcome measures
Perceived Stress Scale
Zarit Burden Inventory (ZBI)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Mindfulness Based Cognitive TherapyExperimental Treatment1 Intervention
Mindfulness-Based Cognitive Therapy (MBCT) combines the ideas of cognitive therapy with meditative practices and attitudes based on the cultivation of mindfulness. The heart of this work lies in becoming acquainted with the modes of mind that often characterize mood disorders while simultaneously learning to develop a new relationship to them.
Group II: Behavior ActivationExperimental Treatment1 Intervention
BA Increase reinforcing behaviors in order to influence emotions and cognitions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Based Cognitive Therapy
2014
Completed Phase 4
~2080
Behavior Activation
2014
N/A
~60

Find a Location

Who is running the clinical trial?

Texas Tech UniversityLead Sponsor
81 Previous Clinical Trials
9,104 Total Patients Enrolled
1 Trials studying Grief
60 Patients Enrolled for Grief
Jonathan D Singer, Ph.DPrincipal Investigatorjonsinge@ttu.edu

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is an opportunity available to join this clinical trial?

"This clinical trial seeks 60 participants aged between 18 and 120 who are afflicted with grief. To qualify, they must also fulfill the following qualifications: informal caregivers of individuals with dementia (related by blood or close friendship), competent English-speakers, a diagnosis of Generalized Anxiety Disorder or Major Depressive Disorder."

Answered by AI

Is this research endeavor currently open to recruitment?

"Affirmative. Clinicaltrials.gov lists this clinical trial as actively recruiting, with a first post date of February 1st 2022 and most recent update on April 11th 2022. The research is enrolling 60 patients from one medical centre."

Answered by AI

How many participants are included in the experiment?

"Affirmative. Data on clinicaltrials.gov evinces that this experiment, which was initially posted on February 1st 2022, is presently enlisting patients. Approximately 60 participants need to be recruited from one specific medical centre."

Answered by AI

Would individuals above the age of 18 be eligible to join this trial?

"Our study is welcoming those who are above the age of majority and below 120 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Reducing Mental Health in Informal Caregivers
2022. "Reducing Mental Health in Informal Caregivers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05334992.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top